Albert Seymour
Insider Reports History
- Location
- Bedford, MA
- Signature
- /s/ Paul Alloway, Attorney-in-Fact for Albert Seymour
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Albert Seymour:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Homology Medicines, Inc. | President and Chief Executive Officer, Director | Common Stock | 150,874 | $85,395 | $0.5660 | 06 Sep 2023 | Direct |
| Homology Medicines, Inc. | President and Chief Executive Officer, Director | Restricted Stock Units | 9,380 | $10,789 | $1.15 | 06 Sep 2023 | Direct |
Insider Reports Filed by Albert Seymour
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QTTB | Homology Medicines, Inc. | 06 Sep 2023 | 3 | -$1,665 | 4 | President and Chief Executive Officer, Director | 08 Sep 2023, 16:44 |
| QTTB | Homology Medicines, Inc. | 23 Feb 2023 | 2 | $0 | 4 | President and Chief Executive Officer, Director | 27 Feb 2023, 15:05 |
| QTTB | Homology Medicines, Inc. | 09 Jan 2023 | 0 | $0 | 4/A | President and Chief Executive Officer, Director | 20 Jan 2023, 15:05 |
| QTTB | Homology Medicines, Inc. | 01 Jan 2023 | 4 | $0 | 4 | President and Chief Executive Officer, Director | 04 Jan 2023, 15:35 |
| QTTB | Homology Medicines, Inc. | 06 Sep 2022 | 2 | $0 | 4 | President and Chief Executive Officer Exhibit 24 - Power of Attorney, Director | 08 Sep 2022, 16:05 |
| QTTB | Homology Medicines, Inc. | 21 Apr 2022 | 1 | $0 | 4 | President and Chief Scientific Officer | 21 Apr 2022, 17:31 |
| QTTB | Homology Medicines, Inc. | 24 Feb 2022 | 2 | $0 | 4 | Chief Scientific Officer | 28 Feb 2022, 15:05 |
| QTTB | Homology Medicines, Inc. | 01 Jan 2022 | 3 | -$6,279 | 4 | Chief Scientific Officer | 12 Jan 2022, 15:05 |